BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
2021 · Cancer Cell International · 65 citations
https://doi.org/10.1186/s12935-021-01908-w
X
Xinran Chu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
326
Citations
11
h-index
13
i10-index
Xinran Chu is an academic researcher from Soochow University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 11, co-authored 34 publications.
Papers by this author
worksSuper-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
2022 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-022-02428-9
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
2022 · Journal of Immunology Research · 17 citations
https://doi.org/10.1155/2022/7912484
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1
2023 · Cell Death and Disease · 13 citations
https://doi.org/10.1038/s41419-023-06039-w
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
2021 · Cancer Cell International · 11 citations
https://doi.org/10.1186/s12935-021-02305-z
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia
2024 · Journal of Experimental & Clinical Cancer Research · 11 citations
https://doi.org/10.1186/s13046-024-03130-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat